Skip to content

Clinical effect of intragastric air quantity on the endoscopic diagnostic ability for gastric cancer after Helicobacter pylori-eradication therapy

Clinical effect of intragastric air quantity on the endoscopic diagnostic ability for gastric cancer after Helicobacter pylori-eradication therapy - intragastric air quantity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046113
Enrollment
30
Registered
2021-11-18
Start date
2021-06-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer after Helicobacter pylori-eradication therapy

Interventions

endoscopic observation and marking during gastric insufflation and degassing

Sponsors

Gastroenterology, Faculty of Medicine, Shimane University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Histologically diagnosed as differentiated gastric cancer. 2)Clinically stage IA is suspected. 3)The lesion has a tumor diameter of 2 cm or more, and the macroscopic type is 0-IIb or 0-IIc. 4)After H.pylori-eradication therapy. 5)Negative on two or more H. pylori infection tests (serum antibody, urea breath test, fecal antigen, etc.). 6)General status is expected to be tolerant of endoscopic exam and resection. 7)Prognosis is expected to be improved by endoscopic resection of the lesion. 8) The age at the time of consent is 20 years or older.6 9)Patient agree with the participation in the study.

Exclusion criteria

Exclusion criteria: 1) Sufficient endoscopic observation is difficult. 2) Surgery was selected.

Design outcomes

Primary

MeasureTime frame
Visibility of demarcation line during insufflation and deaeration

Secondary

MeasureTime frame
Effect of intragastric air quantity on the color tone of endoscopic images, correct diagnosis rate of endoscopic range diagnosis for gastric cancer after Helicobacter pylori-eradication therapy

Countries

Japan

Contacts

Public ContactMaki Watanabe

Shimane University Hospital Gastroenterology

maki-w@med.shimane-u.ac.jp+81-85320-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026